Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video) 26 January 2026
Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video) 23 January 2026
Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video)
Pharos Energy Positioned for Growth with Increased Drilling Momentum – Progressive Equity Research 18 December 2025
Elemental Royalty Poised for Growth in the Mid-Tier Precious Metals Sector, Says Cantor Fitzgerald 18 December 2025
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a 106% Potential Upside in Asset Management 5 February 2026
Spire Healthcare Group PLC ORD (SPI.L) Investor Outlook: A 30% Upside Potential Amidst Robust Analyst Support 5 February 2026
Spectris PLC (SXS.L) Stock Analysis: Navigating a 15.71% Potential Downside Amid Growing Revenue 5 February 2026
Supermarket Income REIT PLC ORD (SUPR.L): A 7.35% Dividend Yield and Growth Potential in the Retail REIT Sector 5 February 2026
Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video) 26 January 2026
Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video) 23 January 2026
Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video)
Pharos Energy Positioned for Growth with Increased Drilling Momentum – Progressive Equity Research 18 December 2025
Elemental Royalty Poised for Growth in the Mid-Tier Precious Metals Sector, Says Cantor Fitzgerald 18 December 2025
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a 106% Potential Upside in Asset Management 5 February 2026
Spire Healthcare Group PLC ORD (SPI.L) Investor Outlook: A 30% Upside Potential Amidst Robust Analyst Support 5 February 2026
Spectris PLC (SXS.L) Stock Analysis: Navigating a 15.71% Potential Downside Amid Growing Revenue 5 February 2026
Supermarket Income REIT PLC ORD (SUPR.L): A 7.35% Dividend Yield and Growth Potential in the Retail REIT Sector 5 February 2026
Embecta Corp. (EMBC) Investor Outlook: Exploring a Potential 32% Upside Amidst Healthcare Sector Challenges 16 January 2026
Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Biotech Gem with Over 100% Potential Upside 16 January 2026
Arbutus Biopharma (ABUS) Stock Analysis: A Potential 20% Upside for Risk-Tolerant Investors 16 January 2026
GH Research PLC (GHRS) Stock Analysis: A 92% Upside Potential in the Biotechnology Arena 16 January 2026
KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Exploring a 122% Potential Upside in the Biotech Space 16 January 2026
Inventiva S.A. (IVA): Exploring a 140% Upside Potential with Strong Analyst Consensus 16 January 2026
Delcath Systems, Inc. (DCTH) Investor Outlook: Exploring a Potential 118.74% Upside in the Healthcare Sector 16 January 2026
Butterfly Network, Inc. (BFLY) Stock Analysis: Potential Growth in the Healthcare Sector Despite Current Valuation Challenges 16 January 2026
Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a Challenging Market with Strategic Staffing Solutions 16 January 2026
Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 31.88% Potential Upside Amidst Industry Challenges 16 January 2026
Akso Health Group (AHG) Investor Outlook: Unpacking the 415% Revenue Surge in China’s Healthcare Market 16 January 2026
Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Exploring a Potential 94.68% Upside 16 January 2026
Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Biotechnology Firm with a Potential 133% Upside Gathers Investor Attention 16 January 2026
Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Unveiling a 50% Potential Upside in Biotech 16 January 2026
Stoke Therapeutics, Inc. (STOK) Stock Analysis: Unpacking a 26.79% Upside Potential in Biotech 16 January 2026
Capricor Therapeutics, Inc. (CAPR) Stock Analysis: A Potential 111% Upside in Biotechnology 16 January 2026
Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video) 17 December 2025
Peter Cruddas CEO CMC Markets: Building a Fintech Powerhouse from London to Sydney (Video) 11 December 2025
XP Factory: Escape Hunt Delivers Record Margins as Boom Battle Bar Fuels Top-Line Growth (Video) 10 December 2025
Elemental Royalty Corporation: Unlocking long-term value through high-impact royalties (Video) 10 December 2025
Pharos Energy Positioned for Growth with Increased Drilling Momentum – Progressive Equity Research 18 December 2025
Elemental Royalty Poised for Growth in the Mid-Tier Precious Metals Sector, Says Cantor Fitzgerald 18 December 2025
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video) 26 January 2026
Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video) 23 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a 106% Potential Upside in Asset Management 5 February 2026
Spire Healthcare Group PLC ORD (SPI.L) Investor Outlook: A 30% Upside Potential Amidst Robust Analyst Support 5 February 2026
Spectris PLC (SXS.L) Stock Analysis: Navigating a 15.71% Potential Downside Amid Growing Revenue 5 February 2026
Supermarket Income REIT PLC ORD (SUPR.L): A 7.35% Dividend Yield and Growth Potential in the Retail REIT Sector 5 February 2026
